Whether you're a healthcare provider, patient, caregiver, or investor — we'd like to hear from you.
Have a question about Alsteni Medical or the Alsteni System? Send us a message and we'll get back to you promptly.
Los Angeles, California
Looking for specific information? Patients and caregivers, visit our For Patients page. Healthcare providers, see For Providers.
We typically respond within one business day.
Alsteni Medical is raising a Series Seed to fund clinical validation, regulatory submission, and commercial preparation for the first invisible feeding technology platform.
Request our investor materials to learn about the opportunity, our regulatory pathway, clinical evidence, and team.
510(k) pathway confirmed by FDA via Pre-Submission meeting (December 2025)
Peer-reviewed safety data: zero serious adverse events across 334 tube-days
IP protection through 2039 with additional patents pending and Notice of Allowance received
Two markets, one clearance: $12.1B enteral nutrition + 5–7M GLP-1 discontinuers
21-month path to clearance from funding close, with defined clinical study scope
We'll follow up with our investor materials and schedule a conversation.